欧洲医学成像（3D 和 4D）软件市场 – 行业趋势和 2029 年预测

市场定义分析和见解

预计医学成像（3D 和 4D）软件市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场的复合年增长率为 8.1%。医疗保健支出和资金的增加是预测期内推动市场需求的主要驱动力。

医学成像软件用于查看、训练、存储和共享医疗数据，并提高所选医疗治疗的效率。医学成像软件包括两种成像类型：二维成像和三维成像。该软件允许医疗专业人员跟踪、存档、处理和管理患者图像和管理工作流程。同时，医院、医疗保健专业人员和诊断中心使用放射学软件以电子形式维护患者数据。该软件可以轻松访问患者数据；有助于维护完整的患者数据，包括入院、出院、报告、预约等。放射学软件提高了准确性，减少了由于人为错误而发生的错误。放射学系统细分诊断测试，例如超声、X 射线、MRI、CT 扫描等。这些放射学诊断测试将有助于尽可能轻松地诊断多种慢性疾病，并允许医疗保健专业人员提供更好的治疗。

此外，医学图像分析软件的技术进步，加上计算机辅助诊断应用的不断增加，是推动医学图像分析软件市场增长的其他因素。此外，预计在预测期内，公共和私营部门对医学图像分析软件的投资增加将促进目标市场的发展。

Medical Imaging (3D & 4D) Software Market Dynamics

Drivers

• Technological advancement leading to new product launch

Over the years, the advancement in the technology of healthcare medical imaging has proved to potentially help in operating various patients requiring customized implants in cases of chronic orthopaedic diseases and dental anomalies, among others. Technological advancement like CAD/CAM leads to modification in less expensive and time-consuming procedures than the earlier procedures. The development of innovative software utilizing different technologies such as 3D imaging, 4D imaging proves to be advantageous for healthcare industries. Earlier the traditional devices and methodology lead to the lengthening of procedures leading to further complications.

Key manufacturers are innovating and launching their products in the market, leading to increased revenue generation, boosting the market growth.

• Increase in public-private funding

A major increase in public-private investment to support various projects in the 3D imaging software industry has occurred in recent years. Such research and funding efforts are expected to accelerate products and innovations, propelling the growth of healthcare medical imaging (3D and 4D) software market.

Various organizations have taken initiatives to strengthen the medical imaging market, leading to increased adoption of technology in the healthcare domain across the globe.

Restraint/Opportunity

• Cloud-based image analysis software

The cloud-based model has emerged as an effective solution to deliver image analysis software as it offers enhanced data accessibility and real-time analysis. Cloud-based image analysis solutions help deliver analytical insights from a multi-terabyte database with ease at any location, anytime, and on any platform. In these solutions, every change in data is captured and automatically updated on the dashboard on a real-time basis. Furthermore, a cloud-based imaging solution does not require any up-front capital investment on hardware; reduces the burden on healthcare systems as there is lower/no involvement of in-house IT staff and enables faster data transfer between organizations. Owing to these advantages, in the coming years, the demand for cloud-based image analysis solutions is expected to be high among end users and this is expected to drive the market growth.

To tap the growth opportunities, many companies are undertaking strategic initiatives to launch new products and expand their presence in the cloud-based medical imaging (3D and 4D) software market which is expected to act as driver for the growth of the medical imaging (3D and 4D) software market.

Challenge

• Less adoption of medical imaging software in developing countries

Developing countries are often cut off from global supply chains; however, medical imaging (3D and 4D) software can bring them back into the fold. Medical imaging software would ensure that anyone in developing countries can produce advanced medical tools. The lack of access to the internet, electricity, and power generation prevents medical imaging in developing countries which is expected to act as restrain for the growth of medical imaging (3D and 4D) software market.

The factors such as lack of proper resources, high cost of imaging software, and lack of technological advancement lead to less adoption of medical imaging software in developing countries.

Post COVID-19 Impact on Medical Imaging (3D and 4D) Software Market

COVID-19 has resulted in a substantial increase in demand for medical supplies from healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment in the market. COVID-19 is anticipated to greatly impact the medical imaging (3D and 4D) software market.

Medical Imaging (3D and 4D) Software Scope and Market Size

Medical imaging (3D and 4D) software market is segmented on the basis of type, image type, modality, application and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the Difference in your target markets.

By Type

• Integrated Software
• Standalone Software

根据类型，医学成像（3D 和 4D）软件市场分为集成软件和独立软件。

按图像类型

• 3D 成像
• 4D 成像

根据图像类型，医学成像（3D 和 4D）软件市场分为 3D 成像和 4D 成像。

按方式

• 创伤性脑损伤 (TBI)
• 超声成像
• 射线成像
• 联合治疗

根据模式，医学成像（3D 和 4D）软件市场分为放射成像、超声成像、组合模式和创伤性脑损伤 (TBI)。

按应用

• 骨科
• 牙科应用
• 神经病学
• 心脏病学
• 肿瘤学
• 妇产科
• 乳房X光检查
• 呼吸应用
• 泌尿科和肾脏科
• 其他的

根据应用，医学成像（3D 和 4D）软件市场细分为骨科、肿瘤科、乳房 X 线摄影、呼吸应用、心脏病学、妇产科、神经病学、泌尿科和肾脏病学、牙科应用等。

按最终用户

• 医院
• 诊断中心
• 研究中心
• 其他的

根据最终用户，医学成像（3D 和 4D）软件市场分为医院、诊断中心、研究中心和其他。

医学成像（3D 和 4D）软件市场国家级分析

对医学成像（3D 和 4D）软件市场进行分析，并按类型、图像类型、模式、应用和最终用户提供市场规模信息。

医学成像（3D 和 4D）软件市场报告涵盖的国家包括德国、法国、意大利、英国、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区。

由于主要市场参与者的存在，德国成为主导国家。由于计算机辅助诊断的应用日益广泛，德国预计将实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

竞争格局和医学成像（3D 和 4D）软件市场份额分析

医学成像（3D 和 4D）软件市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对医学成像（3D 和 4D）软件的关注有关。

涉足医学成像（3D 和 4D）软件市场的主要公司有 Carestream Dental LLC、ESAOTE SPA、通用电气公司、Synopsys, Inc.、INFINITT Healthcare Co., Ltd.、MIM Software Inc.、Mirada Medical Limited、Koninklijke Philips NV、ScienceSoft USA Corporation、Siemens Medical Solutions USA, Inc.、Xinapse Systems Ltd、Arterys Inc.、QMENTA、Aidoc、EffectiveSoft Poland、ContextVision AB、Pie Medical Imaging BV、FUJIFILM Visualsonics, Inc.（FUJIFILM 的子公司）、ALPINION MEDICAL SYSTEMS、Materialise 等。

• 2022 年 3 月，Synopsys 宣布推出 Simpleware Release T-2022.03。Simpleware 软件的最新版本包含许多新功能和改进，包括 Simpleware AS Ortho 模块中的新肩部 CT 工具、轮廓测量、改进的 3D 打印功能和主动脉瓣分析。这有助于该公司扩大其产品组合。
• 2021 年 11 月，全球领先的医疗技术供应商荷兰皇家飞利浦在北美放射学会 (RSNA) 年度大会上宣布其 CT 成像产品组合新增了新产品。新款 CT 5100 - Incisive 具有 CT Smart Work flow 功能，这是一套全面的人工智能 (AI) 功能，旨在加速 CT 工作流程、增强诊断信心并最大程度地延长设备正常运行时间，帮助成像服务改善患者治疗效果、提高部门效率、降低运营成本并实现雄心勃勃的财务目标。这有助于该公司扩大其产品组合。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在医学成像（3D 和 4D）软件市场的影响力，这也为组织的利润增长带来了好处。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、欧洲与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-68689